238 related articles for article (PubMed ID: 31362986)
1. Distinct Fcα receptor
Göritzer K; Turupcu A; Maresch D; Novak J; Altmann F; Oostenbrink C; Obinger C; Strasser R
J Biol Chem; 2019 Sep; 294(38):13995-14008. PubMed ID: 31362986
[TBL] [Abstract][Full Text] [Related]
2. Exploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes.
Göritzer K; Maresch D; Altmann F; Obinger C; Strasser R
J Proteome Res; 2017 Jul; 16(7):2560-2570. PubMed ID: 28516782
[TBL] [Abstract][Full Text] [Related]
3. FcαRI binding at the IgA1 C
Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
[TBL] [Abstract][Full Text] [Related]
4. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA
J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070
[TBL] [Abstract][Full Text] [Related]
5. Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.
Gomes MM; Wall SB; Takahashi K; Novak J; Renfrow MB; Herr AB
Biochemistry; 2008 Oct; 47(43):11285-99. PubMed ID: 18826328
[TBL] [Abstract][Full Text] [Related]
6. Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis.
Herr AB; White CL; Milburn C; Wu C; Bjorkman PJ
J Mol Biol; 2003 Mar; 327(3):645-57. PubMed ID: 12634059
[TBL] [Abstract][Full Text] [Related]
7. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
8. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
[TBL] [Abstract][Full Text] [Related]
9. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
[TBL] [Abstract][Full Text] [Related]
10. IgA Fc receptors.
Monteiro RC; Van De Winkel JG
Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of immunoglobulin A influences its receptor binding.
Basset C; Devauchelle V; Durand V; Jamin C; Pennec YL; Youinou P; Dueymes M
Scand J Immunol; 1999 Dec; 50(6):572-9. PubMed ID: 10607305
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor.
Yoo EM; Trinh KR; Lim H; Wims LA; Morrison SL
Mol Immunol; 2011 Sep; 48(15-16):1818-26. PubMed ID: 21632111
[TBL] [Abstract][Full Text] [Related]
13. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster.
Wines BD; Sardjono CT; Trist HH; Lay CS; Hogarth PM
J Immunol; 2001 Feb; 166(3):1781-9. PubMed ID: 11160224
[TBL] [Abstract][Full Text] [Related]
14. Each N-glycan on human IgA and J-chain uniquely affects oligomericity and stability.
Pan S; Manabe N; Ohno S; Komatsu S; Fujimura T; Yamaguchi Y
Biochim Biophys Acta Gen Subj; 2024 Feb; 1868(2):130536. PubMed ID: 38070292
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.
Chintalacharuvu KR; Chuang PD; Dragoman A; Fernandez CZ; Qiu J; Plaut AG; Trinh KR; Gala FA; Morrison SL
Infect Immun; 2003 May; 71(5):2563-70. PubMed ID: 12704129
[TBL] [Abstract][Full Text] [Related]
16. Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants.
Dicker M; Tschofen M; Maresch D; König J; Juarez P; Orzaez D; Altmann F; Steinkellner H; Strasser R
Front Plant Sci; 2016; 7():18. PubMed ID: 26858738
[TBL] [Abstract][Full Text] [Related]
17. Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants.
Dicker M; Maresch D; Strasser R
Bioengineered; 2016 Nov; 7(6):484-489. PubMed ID: 27333379
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
19. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
Aleyd E; Heineke MH; van Egmond M
Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
[TBL] [Abstract][Full Text] [Related]
20. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.
Carayannopoulos L; Hexham JM; Capra JD
J Exp Med; 1996 Apr; 183(4):1579-86. PubMed ID: 8666916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
